Browse > Article
http://dx.doi.org/10.7586/jkbns.2014.16.3.251

Current Status of Interval of Heparin Flushing for Maintenance of an Implanted Port in Solid Tumor Patients  

Kim, Hye Kyung (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea)
Choi, So Eun (Department of Nursing, Mokpo National University)
Lee, Jung Hoon (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea)
We, Eun Sook (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea)
Joh, Hye Jin (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea)
Kim, Kwang Sung (Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea)
Publication Information
Journal of Korean Biological Nursing Science / v.16, no.3, 2014 , pp. 251-257 More about this Journal
Abstract
Purpose: Little is known about appropriate interval periods between the heparin flushing of implanted ports after completion of chemotherapy. The purpose of this study was to describe the current status of interval of heparin flushing for maintenance of an implanted port in solid tumor patients. Methods: We performed a retrospective review of all patients who had undergone implanted port removal in 2012 at the Seoul St. Mary's Hospital. The subjects were 90 patients who, after completion of chemotherapy, retained their ports for extended periods of time. Results: The mean number of flushes of heparin was 4. Compliance with visits for implanted port maintenance varied with the individual, and the mean accession times were in the range between 13 days and 243 days. The overall mean time between flushes was 66 days. One patient showed resistance during flushing. Conclusion: Our results demonstrate that extending the flushing interval to a maximum of 8 weeks remains medically safe. Less frequent heparin flushing of an implanted port decreases medical expenditure and the workload of medical professionals; it also improves the patient's satisfaction.
Keywords
Neoplasms; Vascular access devices; Heparin; Flushing;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Dougherty, L. (2006). Central Venous Access Devices Care and Management. Blackwell Publishing: Oxford.
2 Bae, J. I. (2011). Insertion and management of central venous catheter. Hanyang Medical Reviews, 31(1), 23-31.   DOI
3 Baskin, J. L., Pui, C. H., Reiss, U., Wilimas, J. A., Metzger, M. L., Ribeiro, R. C., et al. (2009). Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet, 374(9684), 159-169.   DOI   ScienceOn
4 Camp-Sorrell, D. (2004). Access device guidelines: Recommendations for nursing practice and education (2nd ed). Pittsburgh, PA: Oncology Nursing Society.
5 Eugenia, G., Rebecca, P., Gary, L. G., & Dennis, K. (2013). Extending the interval for port-a-cath maintenance. Modern Chemotherapy, 2(2), 15-18.   DOI
6 Kefeli, U., Dane, F., Yumuk, P. F., Karamanoglu, A., Iyikesici, S., Basaran, G., et al. (2009). Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. European Journal of Cancer Care, 18(2), 191-194.
7 Green, E., Macartney, G., Zwaal, C., Marchand, P., Kutzscher L., Savage P., et al. (2008). Managing central venous access devices in cancer patients: A practice guideline. Canadian Oncology Nursing Journal, 18(2), 1-9.
8 Hickman, R. O., Buckner, C. D., Clift, R. A., Sanders, J. E., Stewart, P., & Thomas, E. D. (1979). A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surgery Gynaecology & obstetrics, 148(6), 871-875.
9 Mitchell, M. D., Anderson, B. J., Williams, K., & Umscheid, C. A. (2009). Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journal of Advanced Nursing, 65(10), 2007-2021.   DOI
10 Ignatov, A., Ignatov, T., Taran, A., Smith, B., Costa, S. D., & Bischoff, J. (2010). Interval between port catheter flushing can be extended to four months. Gynecologic and Obstetric Investigation, 70(2), 91-94.   DOI
11 Kock, H. J., Pietsch, M., Krause, U., Wilke, H., & Eigler, F. W. (1998). Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World Journal of Surgery, 22(1), 12-16.   DOI   ScienceOn
12 Kuo, Y. S., Schwartz, B., Santiago, J., Anderson, P. S., Fields, A. L., & Goldberg, G. L. (2005). How often should a port-A-cath be flushed? Cancer Investigation, 23(7), 582-585.   DOI
13 Lamont, J. P., McCarty, T. M., Stephens, J. S., Smith, B. A., Carlo, J., Livingston, S. et al. (2003). A randomized trial of valved vs nonvalved implantable ports for vascular access. Baylor University Medical Center Proceeding, 16(4), 384-387.   DOI
14 Odabas, H., Ozdemir, N. Y., Ziraman, I., Aksoy, S., Abali, H., Oksuzoglu, B., et al. (2013). Effect of port-care frequency on venous port catheter-related complications in cancer patients. International Journal of Clinical Oncology, 27. http://dx.doi.org/10.1007/s10147-013 -0609-7   DOI
15 Lersch, C., Kotowa, W., Fung, S., & Janssen, D. (2004). Prophylaxis of port system-associated thrombosis in advanced oncology patients using heparin flushing. Journal of Cancer Research and Clinical Oncology, 130(40), 235-241.   DOI
16 Maki, D. G., Kluger, D. M., & Crnich, C. J. (2006). The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings, 81(9), 1159-1171.   DOI   ScienceOn
17 Vescia, S., Baumgartner, A. K., Jacobs, V. R., Kiechle-Bahat, M., Rody, A., Loibl, S., et al. (2008). Management of venous port systems in oncology: a review of current evidence. Annals of Oncology, 19(1), 9-15.
18 Korean Oncology Nursing Society. (2009). Oncology nursing practice guideline. Asian Oncology Nursing, 9(1), 76-115.